Eating disorders: an overview of treatment responses and the potential impact of vulnerability genes and endophenotypes

Nicolás Ramoz(Inserm), Philip Gorwood(Inserm), Audrey Versini(Inserm)

Expert Opinion on Pharmacotherapy

August 23, 2007

10.1517/14656566.8.13.2029

Cited by 35

Related Papers

How mental health care should change as a consequence of the COVID-19 pandemic

|The Lancet Psychiatry|2020|1.9k

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

|Nature Reviews Drug Discovery|2012|1.3k

The consequences of the COVID-19 pandemic on mental health and implications for clinical practice

|European Psychiatry|2020|1.2k

Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions

|World Psychiatry|2023|751

Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

|American Journal of Psychiatry|2021|707